Engineers Gate Manager’s Aerie Pharmaceuticals AERI Stock Holding History

Engineers Gate Manager’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,600	Closed	-$162K	–	2228
2022 Q2	$162K	Buy	+21,600	New	+$152K	0.01%	1667
2022 Q1	–	Sell	-87,521	Closed	-$614K	–	2486
2021 Q4	$614K	Buy	+87,521	New	+$916K	0.03%	910
2021 Q2	–	Sell	-14,340	Closed	-$256K	–	2164
2021 Q1	$256K	Buy	+14,340	New	+$248K	0.01%	1429
2016 Q4	–	Sell	-29,321	Closed	-$1.11M	–	764
2016 Q3	$1.11M	Buy	+29,321	New	+$647K	0.12%	318

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Engineers Gate Manager's AERI Position: Q3 2022 in Review

Engineers Gate Manager sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 21,600 shares — an estimated $162K sold.

Engineers Gate Manager first reported a position in AERI in Q3 2016 and held it in 4 quarters. The position peaked at $1.11M in Q3 2016. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

Engineers Gate Manager reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Engineers Gate Manager sold 21,600 Aerie Pharmaceuticals shares in Q3 2022, an estimated $162K.
Engineers Gate Manager first reported a position in Aerie Pharmaceuticals in Q3 2016 and held it in 4 quarters.
Engineers Gate Manager's Aerie Pharmaceuticals position peaked at $1.11M in Q3 2016.
156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Engineers Gate Manager's 13F filing for Q3 2022, filed 14 Nov 2022.